Article Information
- Received July 7, 2022
- Revision received December 7, 2022
- Accepted December 10, 2022
- First published December 19, 2022.
- Version of record published February 1, 2023.
Author Information
Author contributions
Author contributions: K.P.C. and S.H.S. designed research; K.P.C. and H.G. performed research; K.P.C. and S.H.S. contributed unpublished reagents/analytic tools; K.P.C. analyzed data; and K.P.C. and S.H.S. wrote the paper.
Disclosures
- Received July 7, 2022.
- Revision received December 7, 2022.
- Accepted December 10, 2022.
This work was supported by Canadian Institutes of Health Research Grant PJT-159559 to S.H.S. K.P.C. was supported by an Ontario Graduate Scholarship, and S.H.S. was supported by a GlaxoSmithKline–Canadian Institutes of Health Research Chair in Neurosciences. We thank Kim Moore, Simone Appaqaq, Catherine Crandell, Jordan Miller, Ethan Heming, and Helen Bretzke for laboratory and technical assistance.
S.H.S. is cofounder and Chief Scientific Officer (CSO) of Kinarm, which commercializes the robotic technology used in the present study. The other authors declare no competing financial interests.
- Correspondence should be addressed to Kevin P. Cross at 13kc18{at}queensu.ca
Funding
Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
PJT-159559
Other Version
- previous version (December 19, 2022).
- You are viewing the most recent version of this article.
